KAP/DAP → effective dose (mSv) and peak skin dose (Gy) for fluoroscopy & interventional procedures
Optional. Reported by modern fluoro systems at the interventional reference point. Used for peak skin dose estimate.
| Procedure | mSv / (Gy·cm²) | Reference |
|---|---|---|
| Diagnostic coronary angiography | 0.20 | NRPB W4 (Hart 1996) |
| PCI | 0.20 | NRPB W4 |
| EP ablation / pacing | 0.18 | Heyer 2010 |
| Cerebral DSA | 0.087 | Bor 2008 |
| Cerebral intervention | 0.087 | Bor 2008 |
| Abdominal/visceral angio | 0.26 | Hart NRPB-R262 |
| Peripheral angiography | 0.16 | Hart NRPB-R262 |
| ERCP | 0.26 | Hart NRPB-R262 |
| Urological fluoroscopy | 0.20 | Hart NRPB-R262 |
| Orthopaedic / spine | 0.10 | Hart NRPB-R262 |
| GI barium | 0.18 | Hart NRPB-R262 |
| Threshold | K_a,r (Gy) | Effect |
|---|---|---|
| Trigger 1 — substantial radiation dose level (SRDL) | ≥ 5 | Document, follow up patient at 30 days |
| Trigger 2 | ≥ 10 | Patient consultation; transient erythema possible |
| Trigger 3 | ≥ 15 | Risk of permanent epilation, late skin changes |
| Threshold for deterministic effects | ≥ 2 (PSD) | Erythema possible (~24-h delay) |
Note: K_a,r is air kerma at the interventional reference point (IRP). Peak skin dose (PSD) is typically 0.5–1.0 × K_a,r depending on field overlap; this calculator uses 0.7 as a default approximation.